These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3387601)

  • 1. [Prospective study to assess the clinical efficacy of bone scintigraphy--some analyses of clinical data].
    Akiyama Y; Yui N; Matsumoto T; Iinuma T; Ishikawa T; Nakajima T; Machida K; Nishikawa J; Iio M; Uno K
    Radioisotopes; 1988 Mar; 37(3):140-7. PubMed ID: 3387601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prospective study to assess the clinical efficacy of bone scintigraphy--ROC analysis].
    Akiyama Y; Yui N; Matsumoto T; Iinuma T; Ishikawa T; Nakajima T; Machida K; Nishikawa J; Iio M; Uno K
    Radioisotopes; 1988 Mar; 37(3):148-54. PubMed ID: 3387602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prospective study to assess the clinical efficacy of bone scintigraphy--methodology and some preliminary results].
    Akiyama Y; Yui N; Matsumoto T; Iinuma T; Tateno Y; Yamasaki T; Ishikawa T; Nakajima T; Machida K; Nishikawa J
    Radioisotopes; 1984 Feb; 33(2):65-72. PubMed ID: 6739859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pattern and distribution of bone metastases in common malignant tumors.
    Kakhki VR; Anvari K; Sadeghi R; Mahmoudian AS; Torabian-Kakhki M
    Nucl Med Rev Cent East Eur; 2013; 16(2):66-9. PubMed ID: 24068635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The early scintigraphic diagnosis of bone metastases in prostatic carcinoma].
    Petrov T; Tsvetkov M; Mladenov D; Kumanov Kh
    Khirurgiia (Sofiia); 1991; 44(5):28-9. PubMed ID: 1844461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What do breast cancer patients benefit from staging bone scintigraphy?
    Koizumi M; Yoshimoto M; Kasumi F; Ogata E
    Jpn J Clin Oncol; 2001 Jun; 31(6):263-9. PubMed ID: 11463804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Bone scintigraphy in prostatic cancer. Correlation with clinical and laboratory features and with survival].
    Lobo G; Ladrón de Guevara D; Salgado G; Donoso G; Bagus F
    Rev Med Chil; 1999 Feb; 127(2):181-8. PubMed ID: 10436698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bony expansion in skeletal metastases from carcinoma of the prostate as seen by bone scintigraphy.
    Resnik CS; Garver P; Resnick D
    South Med J; 1984 Oct; 77(10):1331-5. PubMed ID: 6484659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prospective study to assess the clinical efficacy of bone scintigraphy--comparative study of the efficacy in breast carcinoma and prostate carcinoma].
    Yui N; Akiyama Y; Matsumoto T; Iinuma T; Ishikawa T; Nakajima T; Machida K; Nishikawa J; Iio M; Uno K
    Radioisotopes; 1988 Nov; 37(11):608-14. PubMed ID: 3065834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical use of staging bone scan in patients with breast carcinoma: reevaluation by the 2003 American Joint Committee on Cancer staging system.
    Lee JE; Park SS; Han W; Kim SW; Shin HJ; Choe KJ; Oh SK; Youn YK; Noh DY; Kim SW
    Cancer; 2005 Aug; 104(3):499-503. PubMed ID: 15968691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Staging of prostatic carcinoma with radionuclide bone scintigraphy and lymphography.
    Hayward SJ; McIvor J; Burdge AH; Jewkes RF; Williams G
    Br J Radiol; 1987 Jan; 60(709):79-81. PubMed ID: 3814999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Assessment of solitary hot spots of bone scintigraphy in patients with extraskeletal malignancies].
    Tomoda Y; Ishino Y; Nakata H
    Kaku Igaku; 2001 Nov; 38(6):721-6. PubMed ID: 11806083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Predictive value of prostate-specific antigen and Gleason sum for results of radionuclide bone scintigraphy in patients with prostate cancer].
    Wang TY; Chen XP; Li XS; Jia Yx; Cheng J; Zhang JH; Cai L; Zhang Z; Gong K; He ZS; Zhou LQ
    Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Aug; 44(4):528-34. PubMed ID: 22898839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study on prognostic factors in bone metastases of breast cancer].
    Yamashita K
    Nihon Seikeigeka Gakkai Zasshi; 1988 Mar; 62(3):191-203. PubMed ID: 3392448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of bone scan as a screening work-up in primary and local-regional recurrence of breast cancer.
    Khansur T; Haick A; Patel B; Balducci L; Vance R; Thigpen T
    Am J Clin Oncol; 1987 Apr; 10(2):167-70. PubMed ID: 3565316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical evaluation of bone scintigraphy in patients with prostatic cancer].
    Murai N; Jinnouchi S; Hoshi H; Watanabe K; Shinkawa T
    Kaku Igaku; 1986 Feb; 23(2):115-22. PubMed ID: 3712853
    [No Abstract]   [Full Text] [Related]  

  • 17. A prospective study to evaluate the intra-individual reproducibility of bone scans for quantitative assessment in patients with metastatic prostate cancer.
    Reza M; Kaboteh R; Sadik M; Bjartell A; Wollmer P; Trägårdh E
    BMC Med Imaging; 2018 May; 18(1):8. PubMed ID: 29728144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone scintigraphy in patients with operable breast cancer stages I and II. Final conclusion after five-year follow-up.
    Butzelaar RM; van Dongen JA; de Graaf PW; van der Schoot JB
    Eur J Cancer Clin Oncol; 1984 Jul; 20(7):877-80. PubMed ID: 6540189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved sensitivity in bone scintigraphy using quantitative spinal profile analysis.
    Parker D; Hart GC
    Nucl Med Commun; 1988 Sep; 9(9):631-7. PubMed ID: 3186084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical evaluation of bone metastases from carcinoma of the prostate by bone scintigraphy with 99mTc-phosphorous compounds (author's transl)].
    Bussaka H; Fujimura N; Yamasaki K
    Kaku Igaku; 1980 Apr; 17(3):297-303. PubMed ID: 7392308
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.